Molecular Imaging: Page 122

Spy case raises questions on U.K. radiation response

By Reuters Health

LONDON (Reuters), Dec 4 - If the poisoning of one man can pose such a serious test for the British government, how would it handle a full-scale radiological attack? A week after former Russian spy Alexander Litvinenko was killed by the radioactive poison polonium-210, some security analysts see major flaws in the emergency response system and question its ability to cope with a larger crisis.

December 3, 2006

Radiation traces found on two BA planes in spy probe

By Reuters Health

LONDON (Reuters), Nov 30 - British Airways said on Wednesday that "very low traces" of radiation had been found on two of its aircraft by police probing the death of former Russian spy Alexander Litvinenko.

November 29, 2006

Two studies define role of molecular imaging, therapy in endocrine carcinoma

By Shalmali Pal

Digestive endocrine tumors would seem to be as intricate as the digestive system itself, so it's no wonder that clinicians are searching for the best imaging modality to diagnose, differentiate, and treat endocrine tumors. Two recent studies looked at how molecular imaging and therapy fared in this disease. A group from Poland evaluated endocrine cancer response to treatment with a radiolabeled somatostatin analogue, while researchers in France tested two molecular imaging techniques in endocrine cancers as a tool for diagnosis and staging.

September 13, 2006

GE, PhotoCure expand partnership to U.S. market

By AuntMinnieEurope.com staff writers

GE Healthcare has exercised its exclusive option to license PhotoCure's Hexvix optical molecular imaging agent for the U.S. market.

July 30, 2006

Siemens to acquire Bayer's diagnostic business

By AuntMinnieEurope.com staff writers

Siemens Medical Solutions reported that it has signed an agreement to acquire the diagnostic division of German chemical and pharmaceutical giant Bayer.

June 29, 2006

VisualSonics, Bracco partner

By AuntMinnieEurope.com staff writers

Microimaging technology developer VisualSonics and contrast agent developer Bracco have formed an exclusive partnership.

June 7, 2006